IVLGMLOct 7, 2019

Brain MRI Tumor Segmentation with Adversarial Networks

arXiv:1910.02717v26 citations
Originality Incremental advance
AI Analysis

This work addresses brain tumor segmentation for medical imaging, offering incremental improvements in handling variable MRI data availability.

The authors tackled brain tumor segmentation in MRI by extending SegAN with a different input and modified loss function, achieving improved performance over SegAN when all four MRI modalities are available and showing that transfer learning enhances results with single modalities.

Deep Learning is a promising approach to either automate or simplify several tasks in the healthcare domain. In this work, we introduce SegAN-CAT, an approach to brain tumor segmentation in Magnetic Resonance Images (MRI), based on Adversarial Networks. In particular, we extend SegAN, successfully applied to the same task in a previous work, in two respects: (i) we used a different model input and (ii) we employed a modified loss function to train the model. We tested our approach on two large datasets, made available by the Brain Tumor Image Segmentation Benchmark (BraTS). First, we trained and tested some segmentation models assuming the availability of all the major MRI contrast modalities, i.e., T1-weighted, T1 weighted contrast-enhanced, T2-weighted, and T2-FLAIR. However, as these four modalities are not always all available for each patient, we also trained and tested four segmentation models that take as input MRIs acquired only with a single contrast modality. Finally, we proposed to apply transfer learning across different contrast modalities to improve the performance of these single-modality models. Our results are promising and show that not SegAN-CAT is able to outperform SegAN when all the four modalities are available, but also that transfer learning can actually lead to better performances when only a single modality is available.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes